E-ISFA 2020 3rd Congress of the European Group of the International Society for Apheresis

19. März 2020 - 21. März 2020
Veranstalter: European Group of the International Society for Apheresis E-ISFA


Therapeutic Apheresis represents a field with remarkable new developments in the last years. New approaches, like for instance the CPR-apheresis, appeared to be rather effective with respect to outcome data. Lipoprotein apheresis will be in the focus of several presentations. The role of the extracorporeal therapy on the background of recently introduced lipid-lowering drugs, like PCSK9 inhibitors, bempedoic acid, lomitapide, and new formulations of omega-3 fatty acids, will be discussed. Other new drugs like antisense oligonucleotides against Apo CIII and apo(a) will also be presented. Data from new studies will be summarized. The meeting continues to include presentations on current aspects of immunoadsorption in auto-immune diseases. Cell therapy and photopheresis will be dealt with.


  • Bilderberg Bellevue Hotel Dresden
    Große Meißner Str. 15
    01097 Dresden


Ansprechpartner für Rückfragen

  • Prof. Dr. Ulrich Julius